RasGRP1 is a causal factor in the development of l-DOPA–induced dyskinesia in Parkinson’s disease
出版年份 2020 全文链接
标题
RasGRP1 is a causal factor in the development of l-DOPA–induced dyskinesia in Parkinson’s disease
作者
关键词
-
出版物
Science Advances
Volume 6, Issue 18, Pages eaaz7001
出版商
American Association for the Advancement of Science (AAAS)
发表日期
2020-05-02
DOI
10.1126/sciadv.aaz7001
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson’s disease patients
- (2019) Tommaso Nuzzo et al. Scientific Reports
- A Selective Phosphodiesterase 10A Inhibitor Reduces L -Dopa-Induced Dyskinesias in Parkinsonian Monkeys
- (2018) Goichi Beck et al. MOVEMENT DISORDERS
- Aberrant Striatal Activity in Parkinsonism and Levodopa-Induced Dyskinesia
- (2018) Michael B. Ryan et al. Cell Reports
- The PRIDE database and related tools and resources in 2019: improving support for quantification data
- (2018) Yasset Perez-Riverol et al. NUCLEIC ACIDS RESEARCH
- Human COMT over-expression confers a heightened susceptibility to dyskinesia in mice
- (2017) Oscar Solís et al. NEUROBIOLOGY OF DISEASE
- A DOCK8-WIP-WASp complex links T cell receptors to the actin cytoskeleton
- (2016) Erin Janssen et al. JOURNAL OF CLINICAL INVESTIGATION
- Genetic deletion of Rhes or pharmacological blockade of mTORC1 prevent striato-nigral neurons activation in levodopa-induced dyskinesia
- (2016) Alberto Brugnoli et al. NEUROBIOLOGY OF DISEASE
- RasGRP1 promotes amphetamine-induced motor behavior through a Rhes interaction network ("Rhesactome") in the striatum
- (2016) N. Shahani et al. Science Signaling
- RasGRP1 promotes amphetamine-induced motor behavior through a Rhes interaction network ("Rhesactome") in the striatum
- (2016) N. Shahani et al. Science Signaling
- Glial activation is associated with l-DOPA induced dyskinesia and blocked by a nitric oxide synthase inhibitor in a rat model of Parkinson's disease
- (2015) Mariza Bortolanza et al. NEUROBIOLOGY OF DISEASE
- Loss of glutamic acid decarboxylase (Gad67) in striatal neurons expressing the Drdr1a dopamine receptor prevents l-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned mice
- (2015) K. Zhang et al. NEUROSCIENCE
- Huntingtin promotes mTORC1 signaling in the pathogenesis of Huntington's disease
- (2014) W. M. Pryor et al. Science Signaling
- Dysregulated RasGRP1 Responds to Cytokine Receptor Input in T Cell Leukemogenesis
- (2013) C. Hartzell et al. Science Signaling
- Ras and extracellular signal-regulated kinase signaling in thymocytes and T cells
- (2013) Robert L. Kortum et al. TRENDS IN IMMUNOLOGY
- Structural analysis of autoinhibition in the Ras-specific exchange factor RasGRP1
- (2013) Jeffrey S Iwig et al. eLife
- Orientation and Cellular Distribution of Membrane-bound Catechol-O-methyltransferase in Cortical Neurons
- (2011) Jingshan Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Constitutive abnormal expression of RasGRP-1 isoforms and low expression of PARP-1 in patients with systemic lupus erythematosus
- (2011) MJ Rapoport et al. LUPUS
- Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA–induced dyskinesia
- (2011) Srinivasa Subramaniam et al. NATURE NEUROSCIENCE
- Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease
- (2011) Veronica Francardo et al. NEUROBIOLOGY OF DISEASE
- Phosphodiesterase 4 inhibition enhances the dopamine D1 receptor/PKA/DARPP-32 signaling cascade in frontal cortex
- (2011) Mahomi Kuroiwa et al. PSYCHOPHARMACOLOGY
- Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia
- (2010) Barbara Picconi et al. BRAIN
- Striatal inhibition of PKA prevents levodopa-induced behavioural and molecular changes in the hemiparkinsonian rat
- (2010) Manon Lebel et al. NEUROBIOLOGY OF DISEASE
- Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa-induced dyskinesia
- (2010) S. Fasano et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genetic Inactivation of Dopamine D1 but Not D2 Receptors Inhibits L-DOPA–Induced Dyskinesia and Histone Activation
- (2009) Sanja Darmopil et al. BIOLOGICAL PSYCHIATRY
- Dysregulation of CalDAG-GEFI and CalDAG-GEFII predicts the severity of motor side-effects induced by anti-parkinsonian therapy
- (2009) Jill R. Crittenden et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Striatal Akt/GSK3 signaling pathway in the development of L-Dopa-induced dyskinesias in MPTP monkeys
- (2009) Marc Morissette et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Inhibition of mTOR Signaling in Parkinson's Disease Prevents L-DOPA-Induced Dyskinesia
- (2009) E. Santini et al. Science Signaling
- Amino acid regulation of TOR complex 1
- (2008) Joseph Avruch et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search